X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (58) 58
Book / eBook (30) 30
Newspaper Article (9) 9
Patent (3) 3
Publication (3) 3
Dissertation (2) 2
Magazine Article (2) 2
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
male (16) 16
female (15) 15
middle aged (15) 15
index medicus (12) 12
rivaroxaban (12) 12
adult (10) 10
aged (10) 10
anticoagulants (9) 9
deep-vein thrombosis (9) 9
medicine, general & internal (9) 9
double-blind method (8) 8
surgery (8) 8
thrombosis (8) 8
venous thromboembolism (8) 8
anticoagulants - therapeutic use (7) 7
enoxaparin - therapeutic use (7) 7
hematology (7) 7
heparin (7) 7
molecular-weight heparin (7) 7
peripheral vascular disease (7) 7
united states (7) 7
aged, 80 and over (6) 6
anticoagulants - administration & dosage (6) 6
architecture (6) 6
drug therapy (6) 6
enoxaparin (6) 6
prevention (6) 6
risk factors (6) 6
thromboembolism (6) 6
venous thromboembolism - prevention & control (6) 6
abridged index medicus (5) 5
anticoagulants - adverse effects (5) 5
factor xa inhibitors (5) 5
hemorrhage - chemically induced (5) 5
histoire (5) 5
history (5) 5
orthopedics (5) 5
pulmonary-embolism (5) 5
unfractionated heparin (5) 5
dosage and administration (4) 4
drug administration schedule (4) 4
enoxaparin - administration & dosage (4) 4
factor xa inhibitors - adverse effects (4) 4
follow-up studies (4) 4
heart failure (4) 4
historia (4) 4
morpholines - therapeutic use (4) 4
politics and government (4) 4
population pharmacokinetics (4) 4
prophylaxis (4) 4
thiophenes - therapeutic use (4) 4
thromboprophylaxis (4) 4
time factors (4) 4
acute disease (3) 3
addresses, essays, lectures (3) 3
administration, oral (3) 3
agriculture, cooperative (3) 3
anticoagulants - blood (3) 3
anticoagulants - pharmacology (3) 3
arkitektur (3) 3
arquitectura (3) 3
bone marrow - pathology (3) 3
bouwkunst (3) 3
buddhism (3) 3
burma (3) 3
calibration (3) 3
cardiac & cardiovascular systems (3) 3
care and treatment (3) 3
case studies (3) 3
citizenship (3) 3
collective settlements (3) 3
colony-forming units assay (3) 3
communal settlements (3) 3
communistic settlements (3) 3
dose-response relationship, drug (3) 3
drug monitoring - methods (3) 3
efficacy (3) 3
electronic books (3) 3
embolisms (3) 3
enoxaparin - adverse effects (3) 3
factor xa inhibitors - administration & dosage (3) 3
factor xa inhibitors - therapeutic use (3) 3
factor-xa inhibitor (3) 3
geschichte (3) 3
health aspects (3) 3
heparin - therapeutic use (3) 3
hospitalization (3) 3
human necessities (3) 3
hygiene (3) 3
incidence (3) 3
kibbutz settlements (3) 3
kibbutzes (3) 3
kibbutzim (3) 3
medical or veterinary science (3) 3
medical patients (3) 3
morpholines - administration & dosage (3) 3
morpholines - adverse effects (3) 3
morpholines - blood (3) 3
morpholines - pharmacology (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (19) 19
UTL at Downsview - May be requested (7) 7
UofT at Scarborough - Stacks (5) 5
Architecture Landscape (Shore + Moffat) - Stacks (4) 4
Gerstein Science - Stacks (3) 3
Trinity College (John W Graham) - Stacks (3) 3
Law (Bora Laskin) - Stacks (2) 2
St. Augustine's Seminary - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UofT at Mississauga - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Protected Material (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Trinity College (John W Graham) - Oversize (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Withdrawn (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


New England Journal of Medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 20, pp. 1945 - 1946
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A10541 - A10541
IntroductionThe MAGELLaN Study was a randomized double-blind active (enoxaparin) and placebo controlled study of rivaroxaban (10mg QD) in medically ill... 
Journal Article
European heart journal, ISSN 0195-668X, 06/2019
Stroke is often a devastating event among patients with heart failure with reduced ejection (HFrEF). In COMMANDER HF, rivaroxaban 2.5 mg b.i.d. did not reduce... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1236 - 1236
Abstract Background: Hospitalized medically ill patients are at risk for venous thromboembolism (VTE) for at least 45 days after discharge. This observation... 
Journal Article
Journal Article
CPT: pharmacometrics & systems pharmacology, ISSN 2163-8306, 07/2019
Prothrombin time (PT) is a measure of coagulation status and was assessed in the majority of patients in the rivaroxaban phase II and III clinical trials as a... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2013, Volume 368, Issue 6, pp. 513 - 523
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 02/2012, Volume 107, Issue 2, pp. 379 - 387
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 542 - 542
Abstract Abstract 542 The MAGELLAN Study: An Analysis of Outcomes Utilizing D-dimer. Background: Elevated D-dimer levels appear to be associated with an... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2018, Volume 379, Issue 12, pp. 1118 - 1127
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2018, Volume 379, Issue 14, pp. 1332 - 1342
Patients with heart failure, coronary artery disease, and no atrial fibrillation were randomly assigned to receive 2.5 mg of rivaroxaban twice daily or... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | THERAPY | EFFICACY | WARFARIN | THROMBIN | RANDOMIZED-TRIAL | ASPIRIN | FACTOR XA INHIBITOR | Myocardial Infarction - epidemiology | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Male | Rivaroxaban - adverse effects | Treatment Failure | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Natriuretic Peptide, Brain - blood | Rivaroxaban - therapeutic use | Heart Failure - mortality | Heart Failure - complications | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Coronary Artery Disease - drug therapy | Heart Failure - drug therapy | Stroke Volume | Factor Xa Inhibitors - therapeutic use | Coronary Artery Disease - complications | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Patient Readmission - statistics & numerical data | Heart failure | Rivaroxaban | Care and treatment | Dosage and administration | Safety and security measures | Coronary heart disease | Myocardial infarction | Performance evaluation | Cerebral infarction | Cardiac arrhythmia | Stroke | Heart attacks | Statistical analysis | Research & development--R&D | Embolisms | Coronary artery | Thrombin | Cardiovascular disease | Thrombosis | Patients | Coronary artery disease | Bleeding | Fibrillation | Coronary vessels | Ventricle | Full text | Heart diseases
Journal Article